11-102047872-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_032930.3(CFAP300):c.168C>T(p.Ser56Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0015 in 1,614,200 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0082 ( 23 hom., cov: 32)
Exomes 𝑓: 0.00081 ( 16 hom. )
Consequence
CFAP300
NM_032930.3 synonymous
NM_032930.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.588
Genes affected
CFAP300 (HGNC:28188): (cilia and flagella associated protein 300) Predicted to be located in cytoplasm and motile cilium. Implicated in primary ciliary dyskinesia 38. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 11-102047872-C-T is Benign according to our data. Variant chr11-102047872-C-T is described in ClinVar as [Benign]. Clinvar id is 1681449.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.588 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00819 (1248/152336) while in subpopulation AFR AF= 0.0281 (1169/41576). AF 95% confidence interval is 0.0268. There are 23 homozygotes in gnomad4. There are 575 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 23 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP300 | NM_032930.3 | c.168C>T | p.Ser56Ser | synonymous_variant | 2/7 | ENST00000434758.7 | NP_116319.2 | |
CFAP300 | NM_001363505.2 | c.168C>T | p.Ser56Ser | synonymous_variant | 2/6 | NP_001350434.1 | ||
CFAP300 | NM_001195005.2 | c.168C>T | p.Ser56Ser | synonymous_variant | 2/4 | NP_001181934.1 | ||
CFAP300 | XM_005271713.5 | c.168C>T | p.Ser56Ser | synonymous_variant | 2/6 | XP_005271770.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP300 | ENST00000434758.7 | c.168C>T | p.Ser56Ser | synonymous_variant | 2/7 | 2 | NM_032930.3 | ENSP00000414390.2 | ||
CFAP300 | ENST00000534360.1 | c.168C>T | p.Ser56Ser | synonymous_variant | 2/4 | 1 | ENSP00000435482.1 | |||
CFAP300 | ENST00000530659.1 | n.405C>T | non_coding_transcript_exon_variant | 1/6 | 1 | |||||
CFAP300 | ENST00000526781.5 | c.168C>T | p.Ser56Ser | synonymous_variant | 2/6 | 3 | ENSP00000433074.1 |
Frequencies
GnomAD3 genomes AF: 0.00821 AC: 1250AN: 152218Hom.: 23 Cov.: 32
GnomAD3 genomes
AF:
AC:
1250
AN:
152218
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00218 AC: 548AN: 251390Hom.: 5 AF XY: 0.00153 AC XY: 208AN XY: 135876
GnomAD3 exomes
AF:
AC:
548
AN:
251390
Hom.:
AF XY:
AC XY:
208
AN XY:
135876
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000806 AC: 1178AN: 1461864Hom.: 16 Cov.: 32 AF XY: 0.000704 AC XY: 512AN XY: 727226
GnomAD4 exome
AF:
AC:
1178
AN:
1461864
Hom.:
Cov.:
32
AF XY:
AC XY:
512
AN XY:
727226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00819 AC: 1248AN: 152336Hom.: 23 Cov.: 32 AF XY: 0.00772 AC XY: 575AN XY: 74490
GnomAD4 genome
AF:
AC:
1248
AN:
152336
Hom.:
Cov.:
32
AF XY:
AC XY:
575
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
CFAP300-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at